The study included 110 males, most of whom were white and in their mid-50s
In all experiments, every 48 h cell culture media was replaced
A breakthrough in liver disease treatment A large global study has found that semaglutide, a medication best known for treating type 2 diabetes and obesity under the brand names Ozempic, Rybelsus, and Wegovy, may also be an effective treatment for a serious liver condition called MASH (metabolic dysfunction-associated steatohepatitis)
They need to consider brands outside their current industry, understand usage occasions, address packaging and messaging to align with GLP-1 weight-loss users, leverage purchase-based targeting and consider collaborating with medical professionals to reach consumers in a more holistic way.
Your provider may offer personalized guidance based on your health profile, so feel free to ask about timing that fits your lifestyle